Annis Gardner Whiting Capital Advisors’s Boston Scientific BSX Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-728	Closed	-$45.7K	–	461
2026 Q1	$45.7K	Sell	728 -78	-10%	-$6.24K	0.01%	596
2025 Q4	$76.9K	Sell	806 -289	-26%	-$28.3K	0.01%	451
2025 Q3	$107K	Buy	1,095 +416	+61%	+$43.1K	0.02%	377
2025 Q2	$72.9K	Buy	679 +551	+430%	+$55.8K	0.03%	360
2025 Q1	$12.9K	Hold	128	–	–	0.01%	511
2024 Q4	$11.4K	Buy	128 +36	+39%	+$3.17K	﹤0.01%	516
2024 Q3	$7.71K	Sell	92 -11	-11%	-$867	﹤0.01%	584
2024 Q2	$7.93K	Buy	103 +11	+12%	+$805	﹤0.01%	715
2024 Q1	$6.3K	Buy	92 +11	+14%	+$707	﹤0.01%	735
2023 Q4	$4.68K	Hold	81	–	–	﹤0.01%	549
2023 Q3	$4.28K	Buy	+81	New	+$4.25K	﹤0.01%	546

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's BSX Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 728 shares — an estimated $45.7K sold.

Annis Gardner Whiting Capital Advisors first reported a position in BSX in Q3 2023 and held it in 11 quarters. The position peaked at $107K in Q3 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Annis Gardner Whiting Capital Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Annis Gardner Whiting Capital Advisors sold 728 Boston Scientific shares in Q2 2026, an estimated $45.7K.
Annis Gardner Whiting Capital Advisors first reported a position in Boston Scientific in Q3 2023 and held it in 11 quarters.
Annis Gardner Whiting Capital Advisors's Boston Scientific position peaked at $107K in Q3 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.